Penile metastasis from colon cancer with BRAFV600E mutation treated with BRAF/MEK-targeted therapy plus cetuximab: A case report

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 17, Issue 3

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

HTML

Figures (1-5)

Sum=104

Publishing Process of This Article

Item

Count

Browse

Download

Sum=20

Mar 15, 2025 (publication date) through Feb 21, 2025

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Oncology

ISSN

1948-5204

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Case Report

World J Gastrointest Oncol. Mar 15, 2025; 17(3): 100152
Published online Mar 15, 2025. doi: 10.4251/wjgo.v17.i3.100152

Full Size Figure Download Figure

Figure 2 Changes in tumor markers during treatment. AFP: Alpha fetoprotein; CEA: Carcinoembryonic antigen; CA: Carbohydrate antigen.

Citation: Wu JC, Cheng HX, Lan QS, Xu HY, Zeng YJ, Lai W, Chu ZH. Penile metastasis from colon cancer with BRAF^V600E mutation treated with BRAF/MEK-targeted therapy plus cetuximab: A case report. World J Gastrointest Oncol 2025; 17(3): 100152
URL: https://www.wjgnet.com/1948-5204/full/v17/i3/100152.htm
DOI: https://dx.doi.org/10.4251/wjgo.v17.i3.100152